‘Interview with the Vampire’: Here’s what to expect from Season 2

The first seven episodes were entertaining, as was the Interview with the Vampire swan song. It honours Anne Rice's gothic style and is an adaption of The Vampire Chronicles.

Agencies
The first seven episodes, along with the Interview with the Vampire finale, gave viewers a good time. It is an Anne Rice adaptation of The Vampire Chronicles and honours the Gothic tone of Anne. We see many people get beautifully, gloriously, and violently killed. We saw Louis tear off someone's jaw.

​Market trading guide: Zydus Lifesciences among 4 stock recommendations for Monday​
1/5

During the holiday-shortened week, Nifty ended at close to 17,800 points while Nifty Bank saw some pressure on the final session of the week and ended lower by 0.75%. “The coming week might conclude a road map for the markets till Dec 2022 since we have a mega event of the US Fed. In addition; RBI has scheduled additional MPC meeting on Nov 03, 2022,” said Mehul Kothari - AVP- Technical Research, Anand Rathi Shares & Stock Brokers.



Here are stock 4 recommendations for Monday:
During the holiday-shortened week, Nifty ended at close to 17,800 points while Nifty Bank saw some pressure on the final session of the week and ended lower by 0.75%. “The coming week might conclude ..
Read More
Buy near Rs 610
Target: Rs 645
Stop loss: Rs 590

On the daily scale; we are witnessing a trend line breakout above Rs 605. This breakout also resembles a bullish inverse head and shoulder pattern.

(Mehul Kothari - AVP- Technical Research, Anand Rathi Shares & Stock Brokers)

Buy near Rs 610Target: Rs 645Stop loss: Rs 590On the daily scale; we are witnessing a trend line breakout above Rs 605. This breakout also resembles a bullish inverse head and shoulder pattern.(Mehu..
Read More
Buy near Rs 236
Target: Rs 260
Stop loss: Rs 224

For the last three months; the stock has been trading in a band of Rs 238 - 208. During the last session, it confirmed a range breakout above Rs 238 along with decent volumes.

(Mehul Kothari - AVP- Technical Research, Anand Rathi Shares & Stock Brokers)


Buy near Rs 236Target: Rs 260Stop loss: Rs 224For the last three months; the stock has been trading in a band of Rs 238 - 208. During the last session, it confirmed a range breakout above Rs 238 alon..
Read More
Buying range: Rs 426-432
Target price: Rs 470
Stop loss: Rs 408

Zydus Lifesciences found support around the Rs 319 levels in May, which also roughly coincides with previous intermediate lows of the stock. The stock has subsequently risen and made higher bottoms in the last few months.

In the process, the stock has broken out of a tight range. Momentum readings like the 14-week RSI, too, are in rising mode and not overbought, which is encouraging.

With the intermediate technical setup too looking positive, we believe the stock has the potential to move higher in the coming weeks.

(Subash Gangadharan, Senior Technical and Derivative Analyst, HDFC Securities)
Buying range: Rs 426-432Target price: Rs 470Stop loss: Rs 408Zydus Lifesciences found support around the Rs 319 levels in May, which also roughly coincides with previous intermediate lows of the stoc..
Read More
Selling range-Rs 3,540-3,550 levels.
Downside target: Rs 3,400
Stop loss- Rs 3,640

Divis Lab is in a short-term downtrend as it has been making lower tops and lower bottoms for the last few weeks. On Friday, the stock broke the recent support of Rs 3,562, indicating the downtrend looks set to continue.

Technical indicators are giving negative signals as the stock is now trading below the 20-day and 50-day SMA. Momentum readings like the 14-day RSI are in decline mode, which implies potential for more downsides.

We therefore expect the stock to correct further in the coming sessions.

(Subash Gangadharan, Senior Technical and Derivative Analyst, HDFC Securities)

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Selling range-Rs 3,540-3,550 levels.Downside target: Rs 3,400Stop loss- Rs 3,640Divis Lab is in a short-term downtrend as it has been making lower tops and lower bottoms for the last few weeks. On Fr..
Read More

Rice's novel did not have an ideal stopping point for the Interview with the Vampire to reduce the first season's view time, but it found a good spot. Claudia's and Louis's murder of Lestat happens around the book's halfway and seems like a good send-off for the seven episodes. The first seven episodes, along with the Interview with the Vampire finale, were a good time. It is an Anne Rice adaptation of The Vampire Chronicles and honours the Gothic tone of Anne. We see many people get beautifully, gloriously, and violently killed. We saw Louis tear off someone's jaw. It was refreshing to see that Lestat did not fully die and will make a comeback in the next season. However, we can only assume. While the show is an adaptation, it is still flexible and shows what it needs to. The Vampire Armand was introduced much before it was scheduled.



FAQs:
  1. What is "The Interview with the Vampire?"
    It is an Anne Rice adaptation of The Vampire Chronicles and honors the Gothic tone of Anne.
  2. What do we think about Lestat's return?
    It was refreshing to see that Lestat did not fully die and will make a comeback in the next season. However, we can only assume.
  3. Is the show a perfect adaption of the novel?
    While the show is an adaptation, it is still flexible and shows what it needs to.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › News › International › US News › ‘Interview with the Vampire’: Here’s what to expect from Season 2
Text Size:AAA
Success
This article has been saved

*

+